The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Giovanni Longo

Showing 1-2 of 2 articles
Coronary interventions
One-year outcomes after Absorb bioresorbable vascular scaffold implantation in routine clinical practice
Capranzano P, Longo G, Tamburino Cl, Gargiulo G, Ohno Y, Francaviglia B, La Manna A, Di Salvo M-E, Grasso C, Sgroi C, Capodanno D, Tamburino C
June 10, 2016 | 10.4244/EIJV12I2A28
Safety and effectiveness of the Catania Polyzene-F coated stent in real world clinical practice: 12-month results from the ATLANTA 2 registry
Tamburino C, Capodanno D, Di Salvo M-E, Sanfilippo A, Cascone I, Incardona V, Longo G, Giacoppo D, Capranzano P, Sgroi C, Ussia G, Monaco A, La Manna A
January 20, 2012 | 10.4244/EIJV7I9A169

Latest news

STATE OF THE ART
Transcatheter treatment for tricuspid valve disease
This State-of-the-Art - by F. Praz et al - reviews the available transcatheter therapies, main criteria for patient and device selection, remaining uncertainties, and future directions
November 19, 2021
NEW ISSUE
PCR London Valves Edition: state of the art on transcatheter treatment for tricuspid valve disease, a mini focus on TR; coronary access after TAVI and more…
November 19, 2021
NEWS
EuroIntervention is now on Instagram
November 29, 2021
AHEAD OF PRINT
Long-term impact of OCT-assessed suboptimal stent deployment
Francesco Prati et al.
November 25, 2021
EDITORIAL
Percutaneous tricuspid valve annuloplasty: additional data and remaining questions
Nicole Karam et al.
November 23, 2021
EDITORIAL
Bioprosthetic valve fracture: haemodynamically effective but safe and clinically necessary?
Josep Rodés-Cabau et al.
November 23, 2021
CONSENSUS
Guidelines, consensus & position papers
consult the most recent published guidelines, consensus and position papers
November 29, 2021
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke